http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5286642-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94ff2d78578d95d1e8d3a2233c76188d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0693
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-475
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-475
filingDate 1992-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1994-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4eec9fd53255a4e99a3e56d42974bfc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4692c413cbecedd0e1a5f61a7498d0d7
publicationDate 1994-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5286642-A
titleOfInvention Rat osteosarcoma cell line OSR5TR2
abstract The present invention relates to a novel cell line isolated from a rat osteosarcoma cell line has the following characteristics: a) a non-expressed p53 protein; b) a normal RB-1 gene; c) a 1O* amplified c-myc gene; d) a normal c-fos gene; e) a deregulated immediate early gene response; f) a canalicular network MATRIGEL(Trademark) growth pattern; g) tumorigenic in congenitally athymic mice; h) no alkaline phosphatase activity; i) an ability to produce one or more of the following growth factors: 1) an osteoblastic differentiation growth factor, 2) a non-heparin binding mitogenic growth factor, 3) a first heparin binding mitogenic growth factor, 4) a second heparin binding mitogenic growth factor, and 5) a third heparin binding mitogenic growth factor; and an ability to be serially propagated greater than sixty population doublings. The present invention also relates to growth factors having the characteristics of growth factors isolated from the rat osteosarcoma cell line. The present invention further relates to a process for producing such growth factors.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005276822-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004214241-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7674456-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7498170-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9521918-A1
priorityDate 1992-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423259
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128671575
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409987
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226483760
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23668196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128448066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6197
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127866646
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56976340
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID352546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129445658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414426
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4784
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128713209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135732338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226497032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23693948
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135728745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413143
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135968306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57479296
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129773695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57422521
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500

Total number of triples: 63.